Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by usi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506123000910 |
_version_ | 1797816008487993344 |
---|---|
author | Alexandra Viktoria Busley Mandy Kleinsorge Lukas Cyganek |
author_facet | Alexandra Viktoria Busley Mandy Kleinsorge Lukas Cyganek |
author_sort | Alexandra Viktoria Busley |
collection | DOAJ |
description | Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by using CRISPR/Cas9 technology. The established KRASG12V iPSC line allows the study of oncogenic KRAS-induced signaling dysregulation and its impact on cell physiology in various iPSC-derived cell types and tissues. Furthermore, it might serve as a powerful platform for drug and toxicity screenings to identify new chemotherapeutic drugs. |
first_indexed | 2024-03-13T08:31:18Z |
format | Article |
id | doaj.art-d41ae05f63d64ff78da7c1f5e75123a9 |
institution | Directory Open Access Journal |
issn | 1873-5061 |
language | English |
last_indexed | 2024-03-13T08:31:18Z |
publishDate | 2023-06-01 |
publisher | Elsevier |
record_format | Article |
series | Stem Cell Research |
spelling | doaj.art-d41ae05f63d64ff78da7c1f5e75123a92023-05-31T04:44:13ZengElsevierStem Cell Research1873-50612023-06-0169103105Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12VAlexandra Viktoria Busley0Mandy Kleinsorge1Lukas Cyganek2Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Göttingen, Germany & Hertha Sponer College, Göttingen, GermanyStem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; Institute of Health in der Charité (BIH), Center of Biological Design, Berlin, GermanyStem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Göttingen, Germany & Hertha Sponer College, Göttingen, Germany; Corresponding author.Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by using CRISPR/Cas9 technology. The established KRASG12V iPSC line allows the study of oncogenic KRAS-induced signaling dysregulation and its impact on cell physiology in various iPSC-derived cell types and tissues. Furthermore, it might serve as a powerful platform for drug and toxicity screenings to identify new chemotherapeutic drugs.http://www.sciencedirect.com/science/article/pii/S1873506123000910 |
spellingShingle | Alexandra Viktoria Busley Mandy Kleinsorge Lukas Cyganek Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V Stem Cell Research |
title | Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V |
title_full | Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V |
title_fullStr | Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V |
title_full_unstemmed | Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V |
title_short | Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V |
title_sort | generation of a genetically modified induced pluripotent stem cell line harboring an oncogenic gene variant kras p g12v |
url | http://www.sciencedirect.com/science/article/pii/S1873506123000910 |
work_keys_str_mv | AT alexandraviktoriabusley generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v AT mandykleinsorge generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v AT lukascyganek generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v |